External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home APAO 2021
Roche and Genentech at

APAO 2021

September 05 - September 11
Virtual
apaophth.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
07:30 PM
Duration 60mins Virtual
Watch the symposium 'Optimising nAMD and DME management through longer-acting therapies'
Wong TY, Chen S-J, Wieland MR, Lai TYY
Ophthalmology | Neovascular Age Related Macular Degeneration - Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
08:45 PM
Duration 5mins Virtual
PDS Surgical Pearls with Archway Sept 2020 data cut
Chang A, Barteselli G, Kaufman D, Makadia S, Malhotra V, Morral M
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Virtual
Faricimab in Neovascular Age-Related Macular Degeneration: 1-Year Results from the Phase 3 TENAYA and LUCERNE Trials
Koizumi H, Holz F, Lin H, Basu K, Quezada Ruiz C, Wong T
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Virtual
Role of Dual Inhibition of Ang-2 and VEGF-A in Patients with Macular Edema Due to Branch or Central/Hemiretinal Retinal Vein Occlusion: Rationale and Design of the Faricimab Phase 3 BALATON and COMINO Trials
Hwang YS, Jain N, Abreu F, Haskova Z, Lin H, Hattenbach LO
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Virtual
Exploring Angiopoetin (Ang)-2 Signaling in Vascular Stability in Patients With Diabetic Macular Edema (DME) Receiving Faricimab in Phase 2 and Phase 3 Trials
Watanachai N, Haskova Z, Willis J, Edmonds R, Westenskow P, Csaky K
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
05:00 PM
Duration 5mins Virtual
Pharmacokinetic Profile of the Port Delivery System With Ranibizumab (PDS) in the Phase 2 Ladder Trial and Phase 3 Archway Trial in Patients with Neovascular Age-Related Macular Degeneration
Cheung G, Gune S, Maia M, Ding HT, Kaagedal M
Ophthalmology | Neovascular Age Related Macular Degeneration

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 5mins Virtual
Faricimab in Diabetic Macular Edema: One-Year Results From the Phase 3 YOSEMITE and RHINE Trials
Sun X, Haskova Z, Silverman D, Ives J, Basu K, Tadayoni R
Ophthalmology | Diabetic Macular Edema

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.